JP Stock MarketDetailed Quotes

4512 WAKAMOTO PHARMACEUTICAL

Watchlist
  • 246
  • +7+2.93%
20min DelayMarket Closed May 17 15:00 JST
8.54BMarket Cap61.81P/E (Static)

WAKAMOTO PHARMACEUTICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

WAKAMOTO PHARMACEUTICAL Earnings Date

Currency: JPY

Period

FY2024 Annual Report

May 15, 2024

Revenue(YoY)

7.74B

-10.65%
NI to Common Holders(YoY)

108.00M

-21.88%
Analyst Rating

No Data

WAKAMOTO PHARMACEUTICAL Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Feb 5, 20242024/Q31.968B / ----
Aug 4, 20232024/Q11.860B / ----
Feb 2, 20232023/Q32.248B / ----
Aug 4, 20222023/Q12.023B / ----
Feb 2, 20222022/Q32.259B / ----
Aug 4, 20212022/Q11.965B / ----
Feb 2, 20212021/Q32.394B / ----
Aug 4, 20202021/Q12.130B / ----
Aug 1, 20192020/Q12.738B / ----
DatePeriodRevenue/EstimateEarnings Call
Feb 5, 20242024/Q31.968B / ----
Aug 4, 20232024/Q11.860B / ----
Feb 2, 20232023/Q32.248B / ----
Aug 4, 20222023/Q12.023B / ----
Feb 2, 20222022/Q32.259B / ----
Aug 4, 20212022/Q11.965B / ----
Feb 2, 20212021/Q32.394B / ----
Aug 4, 20202021/Q12.130B / ----
Aug 1, 20192020/Q12.738B / ----
--------

Unlock Free Earnings Estimates

WAKAMOTO PHARMACEUTICAL Earnings Reports

  • WAKAMOTO PHARMACEUTICAL: Summary of financial results for the fiscal year ending 2024/3 [Japanese GAAP] (unconsolidated)

    May 15 01:00

  • WAKAMOTO PHARMACEUTICAL: Notice regarding revisions to earnings forecasts

    Apr 26 01:00

  • Wakamoto Pharmaceutical: Notice regarding revisions to dividend forecasts

    Mar 22 01:00

  • Wakamoto Pharmaceutical: Notice regarding revisions to earnings forecasts

    Mar 8 02:00

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg